Progressive Estrogen Receptor Acquisition During Malignant Transformation: Insights From MCN‐Derived Anaplastic Pancreatic Carcinoma
Pathology International · 2026
DOI: 10.1111/pin.70061 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathology International, 2026. Verfasst von Kei Kono und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Toranomon Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cell Transformation, Neoplastic, Receptors, Estrogen, Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Anaplastic pancreatic carcinoma (APC) arising from mucinous cystic neoplasm (MCN) is rare, with only 12 cases reported. The relationship between pregnancy‐associaed hormonal changes and MCN progression remains poorly understood, particularly regarding hormone receptor expression patterns during malignant transformation. A 34‐year‐old woman presented with persistent abdominal pain 9 months post‐delivery. Imaging revealed an 11 cm multilocular cystic mass in the pancreatic body and tail with mural nodules showing blood flow signals. Laboratory findings demonstrated normal. She underwent distal pancreatectomy and splenectomy and no recurrence at 6‐month follow‐up. Histopathological examination revealed MCN with ovarian‐type stroma progressing from low‐to‐high grade dysplasia, invasive ductal carcinoma, and anaplastic carcinoma with osteoclast‐like giant cells. Immunohistochemically, estrogen receptor (ER) expression showed stepwise pattern: negative in low‐grade dysplasia, strongly positive in high‐grade dysplasia and anaplastic components. Progesterone receptor positivity was observed in stromal and epithelial components, with elevated Ki‐67 correlating with ER expression. This represents first documentation of progressive ER acquisition during MCN malignant transformation, suggesting autonomous hormone production by ovarian‑type stroma may help sustain tumor growth beyond pregnancy. Stepwise ER expression may serve as a biomarker for risk stratification and a potential target for therapy in hormone‐sensitive pancreatic neoplasms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, Toranomon Hospital, Tokyo, Japan.
- Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
- Department of Gastrointestinal Surgery, Toranomon Hospital, Tokyo, Japan.
- Department of Diagnostic Radiology, Toranomon Hospital, Tokyo, Japan.
- Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.
ORCID-Profile: Kei Kono, Ryo Shibayama, Hisashi Murakami, Tomohiko Masumoto, Kosuke Maehara, Tsunao Imamura, Satoshi Okubo, Masaji Hashimoto, Takeshi Fujii
Zitieren
APA
Kono, K., Shibayama, R., Murakami, H., Masumoto, T., Maehara, K., Imamura, T., Okubo, S., Hashimoto, M., Fujii, T., & Takazawa, Y. (2026). Progressive Estrogen Receptor Acquisition During Malignant Transformation: Insights From MCN‐Derived Anaplastic Pancreatic Carcinoma. Pathology International. https://doi.org/10.1111/pin.70061
Vancouver
Kono K, Shibayama R, Murakami H, Masumoto T, Maehara K, Imamura T, et al. Progressive Estrogen Receptor Acquisition During Malignant Transformation: Insights From MCN‐Derived Anaplastic Pancreatic Carcinoma. Pathology International. 2026. doi:10.1111/pin.70061
BibTeX
@article{Kono2026,
author = {Kono, Kei and Shibayama, Ryo and Murakami, Hisashi and Masumoto, Tomohiko and Maehara, Kosuke and Imamura, Tsunao and Okubo, Satoshi and Hashimoto, Masaji and Fujii, Takeshi and Takazawa, Yutaka},
title = {Progressive Estrogen Receptor Acquisition During Malignant Transformation: Insights From MCN‐Derived Anaplastic Pancreatic Carcinoma},
journal = {Pathology International},
year = {2026},
doi = {10.1111/pin.70061}
}
EUVIMED